Skip to main content
Log in
Menu
Find a journal
Publish with us
Track your research
Search
Cart
Home
Reactions Weekly
Volumes and issues
Volume 1993, Issue 1
Reactions Weekly
Publishing model
:
Subscription
Back to overview
Editorial board
Aims and scope
Search all Reactions Weekly articles
Volume 1993, Issue 1
February 2024
167 articles in this issue
Cobimetinib/Vemurafenib
Case report
03 February 2024
Pages: 51 - 51
Cyclophosphamide/Dactinomycin/Vincristine
Case report
03 February 2024
Pages: 52 - 52
Cyclophosphamide/doxorubicin/paclitaxel
Case report
03 February 2024
Pages: 53 - 53
Cyclophosphamide/interferon-beta-1a
Case report
03 February 2024
Pages: 54 - 54
Cyclophosphamide/prednisone
Case report
03 February 2024
Pages: 55 - 55
Dabrafenib/Nivolumab/Trametinib
Case report
03 February 2024
Pages: 56 - 56
Dapagliflozin/sodium-bicarbonate
Case report
03 February 2024
Pages: 57 - 57
Dapsone
Case report
03 February 2024
Pages: 58 - 58
Diclofenac
Case report
03 February 2024
Pages: 59 - 59
Disulfiram
Case report
03 February 2024
Pages: 60 - 60
Dobutamine/Epinephrine/Vasopressin
Case report
03 February 2024
Pages: 61 - 61
Doxorubicin/Ifosfamide
Case report
03 February 2024
Pages: 62 - 62
Dronabinol
Case report
03 February 2024
Pages: 63 - 63
Dupilumab/methylprednisolone
Case report
03 February 2024
Pages: 64 - 64
EGb-761
Case report
03 February 2024
Pages: 65 - 65
Elasomeran
Case report
03 February 2024
Pages: 66 - 66
Elasomeran/Tozinameran
Case report
03 February 2024
Pages: 67 - 67
Elexacaftor/ivacaftor/tezacaftor
Case report
03 February 2024
Pages: 68 - 68
Enoxaparin-sodium
Case report
03 February 2024
Pages: 69 - 69
Enoxaparin-sodium
Case report
03 February 2024
Pages: 70 - 70
Epinephrine
Case report
03 February 2024
Pages: 71 - 71
Epoprostenol/tozinameran
Case report
03 February 2024
Pages: 72 - 72
Ezetimibe
Case report
03 February 2024
Pages: 73 - 73
Famtozinameran/tozinameran
Case report
03 February 2024
Pages: 74 - 74
Faricimab
Case report
03 February 2024
Pages: 75 - 75
Flurbiprofen
Case report
03 February 2024
Pages: 76 - 76
Gefitinib/Immune-globulin/Osimertinib
Case report
03 February 2024
Pages: 77 - 77
Gemcitabine/paclitaxel
Case report
03 February 2024
Pages: 78 - 78
Gentamicin
Case report
03 February 2024
Pages: 79 - 79
Glycopyrrolate/oxybutynin/petrolatum
Case report
03 February 2024
Pages: 80 - 80
Golimumab
Case report
03 February 2024
Pages: 81 - 81
GSK-2321138A
Case report
03 February 2024
Pages: 82 - 82
Heparin
Case report
03 February 2024
Pages: 83 - 83
Heparin/Tozinameran
Case report
03 February 2024
Pages: 84 - 84
Hyaluronic-acid
Case report
03 February 2024
Pages: 85 - 85
Hydroxycarbamide
Case report
03 February 2024
Pages: 86 - 86
Hydroxychloroquine/mycophenolate-mofetil/prednisolone
Case report
03 February 2024
Pages: 87 - 87
Immune-globulin
Case report
03 February 2024
Pages: 88 - 88
Infliximab/Mercaptopurine/Mesalazine
Case report
03 February 2024
Pages: 89 - 89
Interferon-beta-1a
Case report
03 February 2024
Pages: 90 - 90
Iopamidol
Case report
03 February 2024
Pages: 91 - 91
Iopamidol
Case report
03 February 2024
Pages: 92 - 92
Ioversol
Case report
03 February 2024
Pages: 93 - 93
Ipilimumab/Nivolumab
Case report
03 February 2024
Pages: 94 - 94
Ixekizumab
Case report
03 February 2024
Pages: 95 - 95
Lenvatinib
Case report
03 February 2024
Pages: 96 - 96
Levonorgestrel
Case report
03 February 2024
Pages: 97 - 97
Levonorgestrel
Case report
03 February 2024
Pages: 98 - 98
Lidocaine
Case report
03 February 2024
Pages: 99 - 99
Magnesium-sulfate
Case report
03 February 2024
Pages: 100 - 100
Previous
page
1
2
3
4
Next
page
Search
Search by keyword or author
Search
Navigation
Find a journal
Publish with us
Track your research